LWM
ABBV icon

Lyell Wealth Management’s AbbVie ABBV Stock Holding History

Lyell Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$911K Buy
3,619
+1,651
+84% +$355K 0.06% 131
2026
Q1 		$428K Hold
1,968
– – 0.03% 164
2025
Q4 		$450K Buy
1,968
+456
+30% +$104K 0.03% 156
2025
Q3 		$350K Sell
1,512
-8
-0.5% -$1.63K 0.03% 170
2025
Q2 		$282K Sell
1,520
-95
-6% -$17.7K 0.02% 186
2025
Q1 		$338K Hold
1,615
– – 0.03% 165
2024
Q4 		$287K Sell
1,615
-56
-3% -$10.3K 0.03% 172
2024
Q3 		$330K Hold
1,671
– – 0.03% 172
2024
Q2 		$287K Buy
1,671
+64
+4% +$10.6K 0.03% 174
2024
Q1 		$293K Buy
1,607
+25
+2% +$4.31K 0.03% 172
2023
Q4 		$245K Sell
1,582
-82
-5% -$12K 0.03% 175
2023
Q3 		$248K Sell
1,664
-709
-30% -$104K 0.03% 159
2023
Q2 		$320K Sell
2,373
-44
-2% -$6.45K 0.04% 154
2023
Q1 		$385K Buy
2,417
+60
+3% +$9.17K 0.05% 152
2022
Q4 		$381K Buy
2,357
+314
+15% +$48.1K 0.06% 149
2022
Q3 		$274K Sell
2,043
-294
-13% -$42.2K 0.05% 159
2022
Q2 		$358K Buy
2,337
+261
+13% +$39.9K 0.06% 149
2022
Q1 		$336K Buy
2,076
+283
+16% +$41.1K 0.04% 161
2021
Q4 		$243K Sell
1,793
-131
-7% -$15.5K 0.03% 170
2021
Q3 		$208K Sell
1,924
-27
-1% -$3.08K 0.03% 174
2021
Q2 		$220K Sell
1,951
-567
-23% -$63.9K 0.03% 176
2021
Q1 		$272K Buy
+2,518
New +$269K 0.04% 158

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lyell Wealth Management's ABBV Position: Q2 2026 in Review

Lyell Wealth Management increased its AbbVie (ABBV) stake by 84% in Q2 2026, buying an estimated $355K and bringing the position to 3,619 shares worth $911K. The position accounts for 0.06% of the portfolio, ranked #131.

Lyell Wealth Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lyell Wealth Management held 3,619 shares of AbbVie worth $911K as of Q2 2026.
  • Lyell Wealth Management bought 1,651 AbbVie shares in Q2 2026, an estimated $355K.
  • AbbVie made up 0.06% of Lyell Wealth Management's portfolio in Q2 2026, its #131 holding.
  • Lyell Wealth Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lyell Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.